| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |